Updated on 2024/07/03

写真a

 
TAKAHASHI Masahiko
 
Organization
Academic Assembly Institute of Medicine and Dentistry IGAKU KEIRETU Associate Professor
Graduate School of Medical and Dental Sciences Community Disease Control Infectious Disease Control and International Medicine Associate Professor
Title
Associate Professor
External link

Degree

  • 博士(理学) ( 2004.3   筑波大学 )

Research Interests

  • ストレス顆粒

  • 細胞死

  • ヒトT細胞白血病ウイルス1型

  • アグリソーム

  • 神経変性疾患

Research Areas

  • Life Science / Pathological biochemistry

  • Life Science / Cell biology

  • Life Science / Virology

Research History (researchmap)

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control Infectious Disease Control and International Medicine   Associate Professor

    2016.11

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control Infectious Disease Control and International Medicine   Lecturer

    2015.4 - 2016.10

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control   Assistant Professor

    2007.4 - 2015.3

      More details

  • Niigata University   Graduate School of Medical and Dental Sciences   Assistant

    2004.4 - 2007.3

      More details

Research History

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control Infectious Disease Control and International Medicine   Associate Professor

    2016.11

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control Infectious Disease Control and International Medicine   Lecturer

    2015.4 - 2016.10

  • Niigata University   Graduate School of Medical and Dental Sciences Community Disease Control   Assistant Professor

    2007.4 - 2015.3

  • Niigata University   Graduate School of Medical and Dental Sciences   Research Assistant

    2004.4 - 2007.3

Professional Memberships

 

Papers

  • Myeloid-associated differentiation marker is an essential host factor for human parechovirus PeV-A3 entry Reviewed

    Kanako Watanabe, Tomoichiro Oka, Hirotaka Takagi, Sergei Anisimov, Shun-ichi Yamashita, Yoshinori Katsuragi, Masahiko Takahashi, Masaya Higuchi, Tomotake Kanki, Akihiko Saitoh, Masahiro Fujii

    Nature Communications   14 ( 1 )   2023.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Human parechovirus (PeV-A) is an RNA virus that belongs to the family Picornaviridae and it is currently classified into 19 genotypes. PeV-As usually cause mild illness in children and adults. Among the genotypes, PeV-A3 can cause severe diseases in neonates and young infants, resulting in neurological sequelae and death. In this study, we identify the human myeloid-associated differentiation marker (MYADM) as an essential host factor for the entry of six PeV-As (PeV-A1 to PeV-A6), including PeV-A3. The infection of six PeV-As (PeV-A1 to PeV-A6) to human cells is abolished by knocking out the expression of MYADM. Hamster BHK-21 cells are resistant to PeV-A infection, but the expression of human MYADM in BHK-21 confers PeV-A infection and viral production. Furthermore, VP0 capsid protein of PeV-A3 interacts with one extracellular domain of human MYADM on the cell membrane of BHK-21. The identification of MYADM as an essential entry factor for PeV-As infection is expected to advance our understanding of the pathogenesis of PeV-As.

    DOI: 10.1038/s41467-023-37399-8

    researchmap

    Other Link: https://www.nature.com/articles/s41467-023-37399-8

  • USP10 inhibits aberrant cytoplasmic aggregation of TDP-43 by promoting stress granule clearance Reviewed International journal

    Masahiko Takahashi, Hiroki Kitaura, Akiyoshi Kakita, Taichi Kakihana, Yoshinori Katsuragi, Osamu Onodera, Yuriko Iwakura, Hiroyuki Nawa, Masaaki Komatsu, Masahiro Fujii

    Molecular and Cellular Biology   42 ( 3 )   e0039321   2022.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    TDP-43 is a causative factor of amyotrophic lateral sclerosis (ALS). Cytoplasmic TDP-43 aggregates in neurons are a hallmark pathology of ALS. Under various stress conditions, TDP-43 localizes sequentially to two cytoplasmic protein aggregates: stress granules (SGs) first, and then aggresomes. Accumulating evidence suggests that delayed clearance of TDP-43-positive SGs is associated with pathological TDP-43 aggregates in ALS. We found that USP10 promotes the clearance of TDP-43-positive SGs in cells treated with proteasome inhibitor, thereby promoting the formation of TDP-43-positive aggresomes, and the depletion of USP10 increases the amount of insoluble TDP-35, a cleaved product of TDP-43, in the cytoplasm. TDP-35 interacted with USP10 in an RNA-binding dependent manner; however, impaired RNA-binding of TDP-35 reduced the localization in SGs and aggresomes and induced USP10-negative TDP-35 aggregates. Immunohistochemistry showed that most of the cytoplasmic TDP-43/TDP-35-aggregates in the neurons of ALS patients were USP10-negative. Our findings suggest that USP10 inhibits aberrant aggregation of TDP-43/TDP-35 in the cytoplasm of neuronal cells by promoting the clearance of TDP-43/TDP-35-positive SGs and facilitating the formation of TDP-43/TDP-35-positive aggresomes.

    DOI: 10.1128/mcb.00393-21

    PubMed

    researchmap

  • USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity Reviewed International journal

    Junya Sango, Taichi Kakihana, Masahiko Takahashi, Yoshinori Katsuragi, Sergei Anisimov, Masaaki Komatsu, Masahiro Fujii

    Journal of Biological Chemistry   298 ( 1 )   101448 - 101448   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Nrf2 is an antioxidant transcriptional activator in many types of cells, and its dysfunction plays key roles in a variety of human disorders, including Parkinson's disease (PD). PD is characterized by the selective loss of dopaminergic neurons in PD-affected brain regions. Dopamine treatment of neuronal cells stimulates the production of reactive oxygen species (ROS) and increases ROS-dependent neuronal apoptosis. In this study, we found that the ubiquitin-specific protease 10 (USP10) protein reduces dopamine-induced ROS production of neuronal cells and ROS-dependent apoptosis by stimulating the antioxidant activity of Nrf2. USP10 interacted with the Nrf2 activator p62, increased the phosphorylation of p62, increased the interaction of p62 with the Nrf2 inhibitor Keap1, and stimulated Nrf2 antioxidant transcriptional activity. In addition, USP10 augmented dopamine-induced Nrf2 translation. Taken together, these results indicate that USP10 is a key regulator of Nrf2 antioxidant activity in neuronal cells and suggest that USP10 activators are promising therapeutic agents for oxidative stress-related diseases, including PD.

    DOI: 10.1016/j.jbc.2021.101448

    PubMed

    researchmap

  • The optineurin/TIA1 pathway inhibits aberrant stress granule formation and reduces ubiquitinated TDP-43 Reviewed International journal

    Taichi Kakihana, Masahiko Takahashi, Yoshinori Katsuragi, Shun-Ichi Yamashita, Junya Sango, Tomotake Kanki, Osamu Onodera, Masahiro Fujii

    iScience   24 ( 7 )   102733 - 102733   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease characterized by the formation of cytoplasmic ubiquitinated TDP-43 protein aggregates in motor neurons. Stress granules (SGs) are stress-induced cytoplasmic protein aggregates containing various neuropathogenic proteins, including TDP-43. Several studies have suggested that SGs are the initial site of the formation of pathogenic ubiquitinated TDP-43 aggregates in ALS neurons. Mutations in the optineurin (OPTN) and TIA1 genes are causative factors of familial ALS with TDP-43 aggregation pathology. We found that both OPTN depletion and ALS-associated OPTN mutations upregulated the TIA1 level in cells recovered from heat shock, and this upregulated TIA1 increased the amount of ubiquitinated TDP-43. Ubiquitinated TDP-43 induced by OPTN depletion was localized in SGs. Our study suggests that ALS-associated loss-of-function mutants of OPTN increase the amount of ubiquitinated TDP-43 in neurons by increasing the expression of TIA1, thereby promoting the aggregation of ubiquitinated TDP-43.

    DOI: 10.1016/j.isci.2021.102733

    PubMed

    researchmap

  • Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice Reviewed International journal

    Naoyoshi Maeda, Akira Matsuda, Satoko Otsuguro, Masahiko Takahashi, Masahiro Fujii, Katsumi Maenaka

    Vaccines   8 ( 4 )   658 - 658   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Adult T-cell leukemia (ATL) is a CD4+ T-cell neoplasm caused by human T-cell leukemia virus type I. As the prognosis for patients with ATL remains extremely poor due to resistance to conventional chemotherapy regimens, introduction of novel therapeutic agents is needed. Previous studies have reported that nucleosides 2′-deoxy-2′-methylidenecytidine (DMDC) and its derivative 2′-deoxy-2′-methylidene-5-fluorocytidine (FDMDC) exhibit antitumor activities in T-cell acute lymphoblastic leukemia (T-ALL) and solid tumor cell lines. Another nucleoside, 1-(2-azido-2-deoxy-β-D-arabinofuranosyl)cytosine (cytarazid), is considered a therapeutic drug with antitumor activity in human solid tumors. In this study, we investigated the effects of these nucleosides on cell growth in vitro and in vivo using relevant leukemia cell lines and NOD/Shi-scid, IL-2Rgnull (NOG) mice, respectively. The nucleosides demonstrated significant cytotoxic effects in ATL and T-ALL cell lines. Intraperitoneal administration of FDMDC and DMDC into tumor-bearing NOG mice resulted in significant suppression of tumor growth without lethal side effects. Our findings support a therapeutic application of these nucleosides against tumor progression by targeting DNA polymerase-dependent DNA synthesis in patients with ATL.

    DOI: 10.3390/vaccines8040658

    PubMed

    researchmap

  • G3BP1 inhibits ubiquitinated protein aggregations induced by p62 and USP10 Reviewed International journal

    Sergei Anisimov, Masahiko Takahashi, Taichi Kakihana, Yoshinori Katsuragi, Hiroki Kitaura, Lu Zhang, Akiyoshi Kakita, Masahiro Fujii

    Scientific Reports   9 ( 1 )   12896 - 12896   2019.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    <title>Abstract</title>
    The aberrant accumulation of ubiquitinated protein aggregates in cells plays a critical role in the pathogenesis of several degenerative diseases, including Parkinson disease (PD) and cystic fibrosis (CF). In this study, we found that Ras GTPase-activating protein-binding protein 1 (G3BP1) inhibits ubiquitinated protein aggregations induced by p62 and USP10 in cultured cells. p62 is a ubiquitin receptor, and p62 and its binding partner USP10 have been shown to augment ubiquitinated protein aggregation. G3BP1 interacted with p62 and USP10 and inhibited p62/USP10-induced protein aggregation. The G3BP1 inhibition of protein aggregations targeted two aggregation-prone proteins, α-synuclein and CFTR-ΔF508, which are causative factors of PD and CF, respectively. G3BP1 depletion increased the amounts of ubiquitinated α-synuclein and CFTR-ΔF508 protein. A proteasome reporter indicated that G3BP1 depletion inhibits the proteasome activity. We herein present evidence that G3BP1, p62 and USP10 together control ubiquitinated protein toxicity by controlling both ubiquitination and aggregation. Taken together, these results suggest that G3BP1, p62 and USP10 could be therapeutic targets for ubiquitinated protein aggregation disorders, including PD and CF.

    DOI: 10.1038/s41598-019-46237-1

    PubMed

    researchmap

    Other Link: http://www.nature.com/articles/s41598-019-46237-1

  • USP10 is a critical factor for Tau-positive stress granule formation in neuronal cells Reviewed International journal

    Svetlana Piatnitskaia, Masahiko Takahashi, Hiroki Kitaura, Yoshinori Katsuragi, Taichi Kakihana, Lu Zhang, Akiyoshi Kakita, Yuriko Iwakura, Hiroyuki Nawa, Takeshi Miura, Takeshi Ikeuchi, Toshifumi Hara, Masahiro Fujii

    Scientific Reports   9 ( 1 )   10591 - 10591   2019.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Tau aggregates in neurons of brain lesions is a hallmark pathology of tauopathies, including Alzheimer's disease (AD). Recent studies suggest that the RNA-binding protein TIA1 initiates Tau aggregation by inducing the formation of stress granules (SGs) containing Tau. SGs are stress-inducible cytoplasmic protein aggregates containing many RNA-binding proteins that has been implicated as an initial site of multiple pathogenic protein aggregates in several neurodegenerative diseases. In this study, we found that ubiquitin-specific protease 10 (USP10) is a critical factor for the formation of Tau/TIA1/USP10-positive SGs. Proteasome inhibition or TIA1-overexpression in HT22 neuronal cells induced the formation of TIA1/Tau-positive SGs, and the formations were severely attenuated by depletion of USP10. In addition, the overexpression of USP10 without stress stimuli in HT22 cells induced TIA1/Tau/USP10-positive SGs in a deubiquitinase-independent manner. In AD brain lesions, USP10 was colocalized with Tau aggregates in the cell body of neurons. The present findings suggest that USP10 plays a key role in the initiation of pathogenic Tau aggregation in AD through SG formation.

    DOI: 10.1038/s41598-019-47033-7

    PubMed

    researchmap

    Other Link: http://www.nature.com/articles/s41598-019-47033-7

  • USP10 Inhibits Ubiquitinated Protein Oligomer Toxicity by Inducing Protein Aggregates and Aggresomes

    Masahiko Takahashi, Svetlana Piatnitskaia, Sergei Anisimov

    NIIGATA MEDICAL JOURNAL   133 ( 3 )   91 - 96   2019.3

     More details

    Authorship:Lead author   Language:Japanese  

    researchmap

  • USP10 Is a Driver of Ubiquitinated Protein Aggregation and Aggresome Formation to Inhibit Apoptosis Reviewed International journal

    Masahiko Takahashi, Hiroki Kitaura, Akiyoshi Kakita, Taichi Kakihana, Yoshinori Katsuragi, Masaaki Nameta, Lu Zhang, Yuriko Iwakura, Hiroyuki Nawa, Masaya Higuchi, Masaaki Komatsu, Masahiro Fujii

    iScience   9   433 - 450   2018.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Accumulation of ubiquitinated proteins is cytotoxic, but cells inactivate these cytotoxicities by inducing aggresome formation. We found that ubiquitin-specific protease 10 (USP10) inhibits ubiquitinated protein-induced apoptosis by inducing aggresome formation. USP10 interacted with the ubiquitin receptor p62 and the interaction augmented p62-dependent ubiquitinated protein aggregation and aggresome formation, thereby cooperatively inhibiting apoptosis. We provide evidence that USP10/p62-induced protein aggregates inhibit proteasome activity, which increases the amount of ubiquitinated proteins and promotes aggresome formation. USP10 induced aggresomes containing α-synuclein, a pathogenic protein in Parkinson disease, in cultured cells. In Parkinson disease brains, USP10 was colocalized with α-synuclein in the disease-linked aggresome-like inclusion Lewy bodies, suggesting that USP10 inhibits α-synuclein-induced neurotoxicity by promoting Lewy body formation. Collectively, these findings suggest that USP10 is a critical factor to control protein aggregation, aggresome formation, and cytotoxicity in protein-aggregation-related diseases.

    DOI: 10.1016/j.isci.2018.11.006

    PubMed

    researchmap

  • MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia Reviewed

    Takashi Kozakai, Masahiko Takahashi, Masaya Higuchi, Toshifumi Hara, Kousuke Saito, Yuetsu Tanaka, Masayoshi Masuko, Jun Takizawa, Hirohito Sone, Masahiro Fujii

    International Journal of Hematology   107 ( 3 )   337 - 344   2018.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Membrane-associated guanylate kinase with inverted orientation protein 1 (MAGI-1) is a cytoplasmic scaffold protein that interacts with various signaling molecules; it negatively controls the cell growth of various types of cells and positively controls cell-cell interaction. In T cells, MAGI-1 has been shown to inhibit Akt activity through its interaction with PTEN and MEK1. In this study we found that MAGI-1 expression is decreased in multiple (9 out of 15) human T-cell leukemia cell lines, including adult T-cell leukemia (ATL), T-cell acute lymphoblastic leukemia and chronic T-cell lymphocytic leukemia. The overexpression of MAGI-1 protein in a MAGI-1-low ATL cell line reduced cellular growth. While the overexpression of MAGI-1 protein in a MAGI-1-low ATL cell line reduced the Akt and MEK activities, the knockdown of MAGI-1 in a MAGI-1-high ATL cell line augmented the Akt and MEK activities. Collectively, the findings of the present study suggest that the decreased expression of MAGI-1 in human T cells contributes to the development of several types of T-cell leukemia, partly through the stimulation of the Akt and MEK pathways.

    DOI: 10.1007/s12185-017-2359-1

    Scopus

    PubMed

    researchmap

    Other Link: http://link.springer.com/content/pdf/10.1007/s12185-017-2359-1.pdf

  • USP10 Is an Essential Deubiquitinase for Hematopoiesis and Inhibits Apoptosis of Long-Term Hematopoietic Stem Cells Reviewed

    Masaya Higuchi, Hiroki Kawamura, Hideaki Matsuki, Toshifumi Hara, Masahiko Takahashi, Suguru Saito, Kousuke Saito, Shuying Jiang, Makoto Naito, Hiroshi Kiyonari, Masahiro Fujii

    Stem Cell Reports   7 ( 6 )   1116 - 1129   2016.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.stemcr.2016.11.003

    Web of Science

    researchmap

  • Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB Reviewed

    Yosuke Motai, Masahiko Takahashi, Takayuki Takachi, Masaya Higuchi, Toshifumi Hara, Mariko Mizuguchi, Yutaka Aoyagi, Shuji Terai, Yuetsu Tanaka, Masahiro Fujii

    Virus Genes   52 ( 1 )   4 - 13   2016.2

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-015-1277-7

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-015-1277-7/fulltext.html

  • RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells Reviewed

    Suguru Saito, Toshihiko Kawamura, Masaya Higuchi, Takahiro Kobayashi, Manami Yoshita-Takahashi, Maya Yamazaki, Manabu Abe, Kenji Sakimura, Yasuhiro Kanda, Hiroki Kawamura, Shuying Jiang, Makoto Naito, Takumi Yoshizaki, Masahiko Takahashi, Masahiro Fujii

    European Journal of Immunology   45 ( 5 )   1512 - 1523   2015.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/eji.201444977

    Web of Science

    researchmap

  • Human T ‐cell leukemia virus type 1 T ax oncoprotein represses the expression of the BCL 11 B tumor suppressor in T ‐cells Reviewed

    Takayuki Takachi, Masahiko Takahashi, Manami Takahashi‐Yoshita, Masaya Higuchi, Miki Obata, Yukio Mishima, Shujiro Okuda, Yuetsu Tanaka, Masao Matsuoka, Akihiko Saitoh, Patrick L. Green, Masahiro Fujii

    Cancer Science   106 ( 4 )   461 - 465   2015.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/cas.12618

    Web of Science

    CiNii Article

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.12618

  • Downregulation of proapoptotic Bim augments IL ‐2‐independent T‐cell transformation by human T‐cell leukemia virus type‐1 Tax Reviewed

    Masaya Higuchi, Masahiko Takahashi, Yuetsu Tanaka, Masahiro Fujii

    Cancer Medicine   3 ( 6 )   1605 - 1614   2014.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1002/cam4.329

    Web of Science

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.329

  • HTLV-1 Tax oncoprotein stimulates ROS production and apoptosis in T cells by interacting with USP10 Reviewed

    Masahiko Takahashi, Masaya Higuchi, Grace Naswa Makokha, Hideaki Matsuki, Manami Yoshita, Yuetsu Tanaka, Masahiro Fujii

    Blood   122 ( 5 )   715 - 725   2013.8

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:American Society of Hematology  

    <title>Key Points</title>
    Interaction of HTLV-1 Tax with USP10 reduces arsenic-induced stress granule formation and enhances ROS production. USP10 controls sensitivities of leukemia cell lines to arsenic-induced apoptosis.

    DOI: 10.1182/blood-2013-03-493718

    Web of Science

    researchmap

  • Human T-cell leukemia virus type 1 Tax protein interacts with and mislocalizes the PDZ domain protein MAGI-1 Reviewed

    Grace Naswa Makokha, Masahiko Takahashi, Masaya Higuchi, Suguru Saito, Yuetsu Tanaka, Masahiro Fujii

    Cancer Science   104 ( 3 )   313 - 320   2013.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/cas.12087

    Web of Science

    researchmap

  • Stress Granules Inhibit Apoptosis by Reducing Reactive Oxygen Species Production Reviewed

    M. Takahashi, M. Higuchi, H. Matsuki, M. Yoshita, T. Ohsawa, M. Oie, M. Fujii

    Molecular and Cellular Biology   33 ( 4 )   815 - 829   2013.2

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    DOI: 10.1128/mcb.00763-12

    Scopus

    PubMed

    researchmap

  • Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells Reviewed

    Michitaka Imai, Masaya Higuchi, Hiroki Kawamura, Manami Yoshita, Masahiko Takahashi, Masayasu Oie, Hideaki Matsuki, Yuetsu Tanaka, Yutaka Aoyagi, Masahiro Fujii

    Virus Genes   46 ( 1 )   39 - 46   2013.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-012-0831-9

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-012-0831-9/fulltext.html

  • Both G3BP1 and G3BP2 contribute to stress granule formation Reviewed

    Hideaki Matsuki, Masahiko Takahashi, Masaya Higuchi, Grace N Makokha, Masayasu Oie, Masahiro Fujii

    Genes to Cells   18 ( 2 )   135 - 146   2013.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/gtc.12023

    Web of Science

    researchmap

  • Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus Reviewed

    Yoko Aida, Hironobu Murakami, Masahiko Takahashi, Shin-Nosuke Takeshima

    Frontiers in Microbiology   4   2013

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    DOI: 10.3389/fmicb.2013.00328

    Web of Science

    researchmap

  • Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth Reviewed

    Manami Yoshita, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Masahiro Fujii

    Cancer Science   103 ( 2 )   369 - 374   2012.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/j.1349-7006.2011.02123.x

    Web of Science

    researchmap

  • The PDZ domain binding motif (PBM) of human T-cell leukemia virus type 1 Tax can be substituted by heterologous PBMs from viral oncoproteins during T-cell transformation Reviewed

    Tomoya Aoyagi, Masahiko Takahashi, Masaya Higuchi, Masayasu Oie, Yuetsu Tanaka, Tohru Kiyono, Yutaka Aoyagi, Masahiro Fujii

    Virus Genes   40 ( 2 )   193 - 199   2010.4

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-009-0447-x

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-009-0447-x/fulltext.html

  • Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB Reviewed

    Tiejun Zhao, Jun-ichirou Yasunaga, Yorifumi Satou, Mitsuyoshi Nakao, Masahiko Takahashi, Masahiro Fujii, Masao Matsuoka

    Blood   113 ( 12 )   2755 - 2764   2009.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Society of Hematology  

    <title>Abstract</title>Adult T-cell leukemia (ATL) is a highly aggressive T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1). The activation of NF-κB by Tax has been reported to play a crucial role in HTLV-1–induced transformation. The HTLV-1 bZIP factor (HBZ), which is encoded by an mRNA of the opposite polarity of the viral genomic RNA, is involved in both T cell proliferation and suppression of Tax-mediated viral gene transcription, suggesting that HBZ cooperates closely with Tax. In the present study, we observed that HBZ specifically suppressed NF-κB–driven transcription mediated by p65 (the classical pathway) without inhibiting the alternative NF-κB signaling pathway. In an immunoprecipitation assay, HBZ bound to p65 and diminished the DNA binding capacity of p65. In addition, HBZ induced p65 degradation through increasing the expression of the PDLIM2 gene, which encodes a ubiquitin E3 ligase for p65. Finally, HBZ actually repressed the transcription of some classical NF-κB target genes, such as IL-8, IL2RA, IRF4, VCAM-1, and VEGF. Selective suppression of the classical NF-κB pathway by HBZ renders the alternative NF-κB pathway predominant after activation of NF-κB by Tax or other stimuli, which might be critical for oncogenesis.

    DOI: 10.1182/blood-2008-06-161729

    Web of Science

    researchmap

  • Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2 Reviewed

    Toshiyuki Shoji, Masaya Higuchi, Rie Kondo, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Yutaka Aoyagi, Masahiro Fujii

    Retrovirology   6 ( 1 )   83 - 83   2009

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1186/1742-4690-6-83

    Web of Science

    researchmap

  • Human T-cell leukemia virus type 1 Tax induces an aberrant clustering of the tumor suppressor Scribble through the PDZ domain-binding motif dependent and independent interaction Reviewed

    Masaaki Okajima, Masahiko Takahashi, Masaya Higuchi, Toshiaki Ohsawa, Sakiko Yoshida, Yutaka Yoshida, Masayasu Oie, Yuetsu Tanaka, Fumitake Gejyo, Masahiro Fujii

    Virus Genes   37 ( 2 )   231 - 240   2008.10

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-008-0259-4

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-008-0259-4/fulltext.html

  • Knockdown of synapse-associated protein Dlg1 reduces syncytium formation induced by human T-cell leukemia virus type 1 Reviewed

    Sakiko Yoshida, Masaya Higuchi, Toshiyuki Shoji, Manami Yoshita, Kojiro Ishioka, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Makoto Uchiyama, Masahiro Fujii

    Virus Genes   37 ( 1 )   9 - 15   2008.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-008-0234-0

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-008-0234-0/fulltext.html

  • Rearranged NF-κB2 gene in an adult T-cell leukemia cell line Reviewed

    Masato Isogawa, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Naoki Mori, Yuetsu Tanaka, Yutaka Aoyagi, Masahiro Fujii

    Cancer Science   99 ( 4 )   792 - 798   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/j.1349-7006.2008.00750.x

    Web of Science

    CiNii Article

    CiNii Books

    researchmap

  • Cooperation of NF-κB2/p100 Activation and the PDZ Domain Binding Motif Signal in Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax1 but Not HTLV-2 Tax2 Is Crucial for Interleukin-2-Independent Growth Transformation of a T-Cell Line Reviewed

    Masaya Higuchi, Chikako Tsubata, Rie Kondo, Sakiko Yoshida, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Renaud Mahieux, Masao Matsuoka, Masahiro Fujii

    Journal of Virology   81 ( 21 )   11900 - 11907   2007.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    <title>ABSTRACT</title>
    Human T-cell leukemia virus type 1 (HTLV-1) but not HTLV-2 is associated with adult T-cell leukemia, and the distinct pathogenicity of these two closely related viruses is thought to stem from the distinct biological functions of the respective transforming proteins, HTLV-1 Tax1 and HTLV-2 Tax2. In this study, we demonstrate that Tax1 but not Tax2 interacts with NF-κB2/p100 and activates it by inducing the cleavage of p100 into the active transcription factor p52. Using RNA interference methods, we further show that NF-κB2/p100 is required for the transformation induced by Tax1, as determined by the ability to convert a T-cell line (CTLL-2) from interleukin-2 (IL-2)-dependent to -independent growth. While Tax2 shows a reduced transforming activity relative to Tax1, Tax2 fused with a PDZ domain binding motif (PBM) present only in Tax1 shows transforming activity equivalent to that of Tax1 in CTLL-2 cells expressing an inducer of p52 processing. These results reveal that the activation of NF-κB2/p100 plays a crucial role in the Tax1-mediated transformation of T cells and that NF-κB2/p100 activation and PBM function are both responsible for the augmented transforming activity of Tax1 relative to Tax2, thus suggesting that these Tax1-specific functions play crucial roles in HTLV-1 leukemogenesis.

    DOI: 10.1128/jvi.00532-07

    Web of Science

    researchmap

  • A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences Reviewed

    Akiko Watanabe, Masaya Higuchi, Masaya Fukushi, Toshiaki Ohsawa, Masahiko Takahashi, Masayasu Oie, Masahiro Fujii

    Virus Genes   34 ( 2 )   127 - 136   2007.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s11262-006-0048-x

    Web of Science

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s11262-006-0048-x/fulltext.html

  • Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line. Reviewed

    Rie Kondo, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Fumitake Gejyo, Masahiro Fujii

    Retrovirology   3 ( 1 )   88 - 88   2006

     More details

    Publisher:Springer Science and Business Media LLC  

    DOI: 10.1186/1742-4690-3-88

    Web of Science

    researchmap

  • Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein. Reviewed

    Kojiro Ishioka, Masaya Higuchi, Masahiko Takahashi, Sakiko Yoshida, Masayasu Oie, Yuetsu Tanaka, Sugata Takahashi, Li Xie, Patrick L Green, Masahiro Fujii

    Retrovirology   3 ( 1 )   71 - 71   2006

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1186/1742-4690-3-71

    Web of Science

    researchmap

  • Aberrant Activation of the Interleukin-2 Autocrine Loop through the Nuclear Factor of Activated T Cells by Nonleukemogenic Human T-Cell Leukemia Virus Type 2 but Not by Leukemogenic Type 1 Virus Reviewed International journal

    Akiko Niinuma, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Fumitake Gejyo, Nobuyuki Tanaka, Kazuo Sugamura, Li Xie, Patrick L. Green, Masahiro Fujii

    Journal of Virology   79 ( 18 )   11925 - 11934   2005.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    <title>ABSTRACT</title>
    Human T-cell leukemia virus type 1 (HTLV-1) but not HTLV-2 is associated with adult T-cell leukemia. We found that HTLV-2 Tax2 protein stimulated reporter gene expression regulated by the interleukin (IL)-2 promoter through the nuclear factor of activated T cells (NFAT) in a human T-cell line (Jurkat). However, the activity of HTLV-1 Tax1 was minimal in this system. T-cell lines immortalized by HTLV-2 but not HTLV-1 constitutively exhibited activated NFAT in the nucleus and constitutively expressed IL-2 mRNA. Cyclosporine A, an inhibitor of NFAT activation, abrogated the induction of IL-2 mRNA in HTLV-2-immortalized T-cell lines and concomitantly inhibited cell growth. This growth inhibition was rescued by the addition of IL-2 to the culture. Furthermore, anti-IL-2 receptor antibodies significantly reduced the proliferation of HTLV-2-infected T-cell lines but not that of HTLV-1-infected cells. Our results suggest that Tax2 activates an IL-2 autocrine loop mediated through NFAT that supports the growth of HTLV-2-infected cells under low-IL-2 conditions. This mechanism would be especially important in vivo, where this autocrine mechanism establishes a nonleukemogenic life-long HTLV-2 infection. The results also suggest that differences in long-term cytokine production between HTLV-1 and HTLV-2 infection are another factor for the differences in pathogenesis.

    DOI: 10.1128/jvi.79.18.11925-11934.2005

    Web of Science

    PubMed

    researchmap

  • Involvement of bovine leukemia virus in induction and inhibition of apoptosis Reviewed

    Masahiko Takahashi, Shigeru Tajima, Kosuke Okada, William C. Davis, Yoko Aida

    Microbes and Infection   7 ( 1 )   19 - 28   2005.1

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.micinf.2004.09.014

    Web of Science

    researchmap

  • Bovine Leukemia Virus High Tax Molecular Clone Experimentally Induces Leukemia/Lymphoma in Sheep Reviewed

    Kosuke OKADA, Norihiro NAKAE, Konomi KURAMOCHI, Shan-ai YIN, Manabu IKEDA, Shigeaki TAKAMI, Tou-ichi HIRATA, Masanobu GORYO, Shigeru NUMAKUNAI, Shin-nosuke TAKESHIMA, Masahiko TAKAHASHI, Shigeru TAJIMA, Satoru KONNAI, Misao ONUMA, Yoko AIDA

    Journal of Veterinary Medical Science   67 ( 12 )   1231 - 1235   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society of Veterinary Science  

    Sheep were inoculated with high tax coded pBLV-IF (H group, Nos. 1-5) of bovine leukemia virus (BLV), wild tax coded pBLV-IF (W group, Nos. 6-11), or control plasmid (C group, Nos. 12-14). During the observation period (4 to 46 months), 5 of 5 cases in H group and 3 of 6 cases (Nos. 6, 7, 9) in W group became positive for gp 51. Only 1 case in H group became leukemic, and one case each of H and W groups developed lymphoma. In No. 3, lesions were found in multiple organs including the lymph nodes, gastrointestinal tract following abomasum, and heart. In No. 6, lesions of lymphoma were found only in the jejunum and heart. Morphologically, small to middle-sized lymphocytic neoplastic (NP) cells were found in both cases, but lymphoblastic NP cells were found only in No. 3. By immunohistochemical examination, the phenotypes of NP cells were determined as CD1^-, CD4^-, CD5^--, CD8α^-, sIgM^+, λlight chain^+, B-B4^+, MHC class II^+ in both case. The results of this study indicate that inoculation of pBLV-IF can induce lymphocytic and lymphoblastic leukemia/lymphoma in sheep. Additionally, it is suggested that the expression rate of tax gene is not associated with the development of leukemia/lymphoma in sheep experimentally inoculated with pBLV-IF.

    DOI: 10.1292/jvms.67.1231

    Web of Science

    CiNii Article

    CiNii Books

    researchmap

  • Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation. Reviewed International journal

    Masaya Higuchi, Takehiro Matsuda, Naoki Mori, Yasuaki Yamada, Ryouichi Horie, Toshiki Watanabe, Masahiko Takahashi, Masayasu Oie, Masahiro Fujii

    Retrovirology   2 ( 1 )   29 - 29   2005

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    BACKGROUND: Human T-cell leukemia virus type 1 (HTLV-1) is associated with the development of adult T-cell leukemia (ATL). HTLV-1 encoded Tax1 oncoprotein activates the transcription of genes involved in cell growth and anti-apoptosis through the NF-kappaB pathway, and is thought to play a critical role in the pathogenesis of ATL. While Tax1 expression is usually lost or minimal in ATL cells, these cells still show high constitutive NF-kappaB activity, indicating that genetic or epigenetic changes in ATL cells induce activation independent of Tax1. The aim of this study was to identify the molecules responsible for the constitutive activation of NF-kappaB in ATL cells using a retroviral functional cloning strategy. RESULTS: Using enhanced green fluorescent protein (EGFP) expression and blasticidin-resistance as selection markers, several retroviral cDNA clones exhibiting constitutive NF-kappaB activity in Rat-1 cells, including full-length CD30, were obtained from an ATL cell line. Exogenous stable expression of CD30 in Rat-1 cells constitutively activated NF-kappaB. Elevated expression of CD30 was identified in all ATL lines examined, and primary ATL cells from a small number of patients (8 out of 66 cases). CONCLUSION: Elevated CD30 expression is considered one of the causes of constitutive NF-kappaB activation in ATL cells, and may be involved in ATL development.

    DOI: 10.1186/1742-4690-2-29

    Web of Science

    PubMed

    researchmap

  • PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line. Reviewed

    Chikako Tsubata, Masaya Higuchi, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Fumitake Gejyo, Masahiro Fujii

    Retrovirology   2 ( 1 )   46 - 46   2005

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1186/1742-4690-2-46

    Web of Science

    researchmap

  • Ex vivo survival of peripheral blood mononuclear cells in sheep induced by bovine leukemia virus (BLV) mainly occurs in CD5– B cells that express BLV Reviewed International journal

    Masahiko Takahashi, Shigeru Tajima, Shin-Nosuke Takeshima, Satoru Konnai, Shan Ai Yin, Kosuke Okada, William C. Davis, Yoko Aida

    Microbes and Infection   6 ( 6 )   584 - 595   2004.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Bovine leukemia virus (BLV) is the etiologic agent of enzootic bovine leukosis (EBL). In a previous report, we found that in a sheep model, only CD5(-) B cells proliferated clonally, while CD5(+) B cells rapidly decreased when the disease progressed to the lymphoma stage. We demonstrate here that, although both CD5(+) and CD5(-) B cells, but not CD4(+) T, CD8(+) T and gammadeltaTCR(+)T cells, are protected from spontaneous ex vivo apoptosis in sheep infected with wild-type and a mutant BLV that encodes a mutant Tax D247G protein with elevated trans-activation activity, only CD5(-) B cells become the main target for ex vivo survival when the disease proceeds to the persistent lymphocytotic stage, which showed an increased expansion of the CD5(-) B cells. In addition, we identified, by four-color flow cytometric analysis, that in CD5(-) B cells, the apoptotic rates of cells that expressed wild-type and mutant BLV were greatly decreased compared with those of BLV-negative cells. There was only a slight reduction in the apoptotic rates in BLV-positive cells from CD5(+) B cells. In addition, supernatants from peripheral blood mononuclear cell (PBMC) cultures from wild-type- and mutant BLV-infected sheep mainly protected CD5(-) B cells from spontaneous apoptosis. Our results suggest that, although BLV can protect both CD5(+) and CD5(-) B cells from ex vivo apoptosis, the mechanisms accounting for the ex vivo survival between these two B-cell subsets differ. Therefore, it appears that the phenotypic changes in cells that express CD5 at the lymphoma stage could result from a difference in susceptibility to apoptosis in CD5(+) and CD5(-) B cells in BLV-infected sheep.

    DOI: 10.1016/j.micinf.2004.02.014

    Web of Science

    PubMed

    researchmap

  • A Mutant Form of the Tax Protein of Bovine Leukemia Virus (BLV), with Enhanced Transactivation Activity, Increases Expression and Propagation of BLV In Vitro but Not In Vivo Reviewed

    Shigeru Tajima, Masahiko Takahashi, Shin-nosuke Takeshima, Satoru Konnai, Shan Ai Yin, Shinobu Watarai, Yoshimasa Tanaka, Misao Onuma, Kosuke Okada, Yoko Aida

    Journal of Virology   77 ( 3 )   1894 - 1903   2003.2

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    <title>ABSTRACT</title>
    In a previous study, we identified an interesting mutant form of the Tax protein of bovine leukemia virus (BLV), designated D247G. This mutant protein strongly transactivated the long terminal repeat of BLV and was also able to transactivate the cellular proto-oncogene c-<italic>fos</italic>. This finding suggested that BLV that encode the mutant protein might propagate and induce lymphoma more efficiently than wild-type BLV. To characterize the effects of the strong transactivation activity of the mutant Tax protein, we constructed an infectious molecular clone of BLV that encoded D247G and examined the replication and propagation of the virus in vitro and in vivo. Cultured cells were transfected with the wild-type and mutant BLV, and then levels of viral proteins and particles and the propagation of viruses were compared. As expected, in vitro, mutant BLV produced more viral proteins and particles and was transmitted very effectively. We injected the wild-type and mutant BLV into sheep, which are easily infected with BLV, and monitored the proportion of BLV-positive cells in the blood and the expression of BLV RNA for 28 weeks. By contrast to the results of our analyses in vitro, we found no significant difference in the viral load or the expression of viral RNA between sheep inoculated with wild-type or mutant BLV. Our observations indicate that the mutant D247G Tax protein does not enhance the expansion of BLV and that there might be a dominant mechanism for regulation of the expression of BLV in vivo.

    DOI: 10.1128/jvi.77.3.1894-1903.2003

    Web of Science

    CiNii Article

    researchmap

▶ display all

MISC

  • 成人T細胞白血病ウイルス癌蛋白TaxとHBZはBCL11B遺伝子発現を抑制する(Human T-cell leukemia virus type 1 oncoproteins Tax and HBZ represses BCL11B gene expression)

    高地 貴行, 由田 真奈美, 高橋 雅彦, 樋口 雅也, 大家 正泰, 小幡 美貴, 三嶋 行雄, 木南 凌, 松岡 雅雄, 藤井 雅寛

    日本癌学会総会記事   72回   240 - 240   2013.10

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • Aberrant activation of the interleukin 2 autocrine loop through Nfat by non-leukemogenic human T-cell leukemia virus type 2 but not leukemogenic type 1 virus

    M Fujii, M Takahashi, M Higuchi

    AIDS RESEARCH AND HUMAN RETROVIRUSES   21 ( 5 )   451 - 451   2005.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:MARY ANN LIEBERT INC  

    Web of Science

    researchmap

  • 7 Oncogenesis by a Human Retrovirus (Genome Information and Infection (Application for Diagnosis, Treatment, and Prevention))

    FUJII Masahiro, HIRATA Akira, NIINUMA Akiko, TSUBATA Chikako, ISHIOKA Koujirou, Jo Rie, TAKAHASHI Masahiko, OIE Masayasu, HIGUCHI Masaya

    Niigata medical journal   118 ( 11 )   601 - 606   2004.11

     More details

    Language:Japanese   Publisher:Niigata University  

    Human T-cell leukemia virus type 1 (HTLV-1) is an etiologic agent of adult T-cell leukemia (ATL). Around 5% HTLV-1-infected individuals develop ATL averagely 50-60 years after the infection. Thus, in addition to HTLV-1, multiple host factors are involved in the development of ATL. Unlike to HTLV-1, an allied virus HTLV-2 is not associated with ATL or similar leukemia. HTLV-1 and HTLV-2 immortalizes human T-cells in vitro, and their efficiencies are equivalent. These results suggest that HTLV-1 has additional activities to host T-cells resulting in ATL development. We will discuss the roles of HTLV-1 tax1 and HTLV-2 tax2 genes in the distinct pathogenic activities between two viruses.

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://hdl.handle.net/10191/2541

  • モノクローナル抗体による牛白血病ウイルス表面抗原gp51の検出

    若本 裕晶, 森田 裕, 高橋 雅彦, 間 陽子

    日本獣医学会学術集会講演要旨集   135回   123 - 123   2003.3

     More details

    Language:Japanese   Publisher:(公社)日本獣医学会  

    researchmap

  • Regulation of apoptosis by bovine leukemia virus encoding Tax with elevated transactivation activity.

    M Takahashi, S Tajima, S Takeshima, K Okada, Y Aida

    AIDS RESEARCH AND HUMAN RETROVIRUSES   19   S69 - S70   2003

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:MARY ANN LIEBERT INC PUBL  

    Web of Science

    researchmap

  • BLV感染羊由来PBMCのex vivo培養におけるアポトーシス関連因子の発現

    高橋 雅彦, 田島 茂, 岡田 幸助, 尹 善愛, 高木 道浩, 小沼 操, 間 陽子

    日本獣医学会学術集会講演要旨集   133回   105 - 105   2002.3

     More details

    Language:Japanese   Publisher:(公社)日本獣医学会  

    researchmap

  • In vitro and in vivo analyses of infectious molecular clone of BLV encoding tax with elevated transactivation activity

    S Tajima, M Takahashi, K Okada, Y Aida

    AIDS RESEARCH AND HUMAN RETROVIRUSES   17   S48 - S48   2001

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:MARY ANN LIEBERT INC PUBL  

    Web of Science

    researchmap

▶ display all

Research Projects

  • 多発性骨髄腫患者にて分子標的薬ダラツムマブによる輸血検査偽陽性の新規回避法の確立

    Grant number:21K07201

    2021.4 - 2024.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    川村 宏樹, 高橋 雅彦

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    【目的】再発・難治性の多発性骨髄腫の治療薬として臨床許可されダラツムマブ(DARA)は、腫瘍化で細胞上に発現するCD38をターゲットとする分子標的薬である。CD38は赤血球にも発現していため、DARA投与患者の輸血検査に干渉して偽陽性となり結果判定に影響を与え問題となっている。本研究は赤血球試薬に影響を与えず、DARA投与患者の輸血検査において簡易法で保存可能な腫瘍細胞由来の吸収試薬の開発に結び付く基礎技術の確立を目的とする。令和3年度(1年目)は骨髄腫細胞株を用いて、PBSにDARAを加えた模擬検体、ヒト血漿にDARAを加えた模擬検体の順に検討してDARAの吸収条件検討と吸収効率を検討した。
    【成果】はじめに、実験的にDARAが輸血検査のスクリーニング血球に擬陽性をもたらす条件を検討した。購入したDARAをPBSで報告のある患者血中濃度1,000~1μg/mLまで濃度を振って溶液を作成して、間接抗グロブリン試験(IAT)をおこなった、その結果、通常の不規則抗体陽性の時と異なって試験管の底部に張り付き、崩れていく様相を示した。凝集強度は1+~W+であった。ただし、複数のロットのスクリーニング血球で検討をおこなったところ、濃度と凝集強度の関係にはロット差が認められた。次にPBSをFFP(不規則抗体陰性)で希釈して検討したところ、PBSより試験管底部に張り付くのは弱くかつ凝集強度も弱かった。次にFFPで希釈したDARA(1mg/mL)をCD38陽性骨髄腫細胞株のβ-M細胞を用いて、加温時間、細胞数を変動させて吸着後に遠心して上清を回収してIATをおこなった。しかしながら、毎回安定した結果は得られていない。これはβ細胞の発現量の細胞差の可能性が考えられ再クローン化をおこなうと同時に、他のCD38陽性骨髄腫細胞株でも検討をおこなう予定である。

    researchmap

  • 新規NF-κB抑制因子による炎症性腸疾患における慢性炎症の制御機構

    2017.4 - 2020.3

    System name:科学研究費助成事業

    Awarding organization:日本学術振興会

    川村宏樹

      More details

    Grant type:Competitive

    researchmap

  • プロテアソーム阻害薬に対する感受性を抑制する新しい分子機構の解明

    2017.4 - 2020.3

    System name:科学研究費助成事業

    Awarding organization:日本学術振興会

    高橋雅彦

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • ストレス顆粒とオートファジーによるTDP-43蛋白の分解機構

    2016 - 2018

    System name:医学系研究奨励(基礎)

    Awarding organization:武田科学振興財団

    高橋雅彦

      More details

    Authorship:Principal investigator 

    researchmap

  • 活性酸素制御異常による成人T細胞白血病発症機構の解明

    2014.4 - 2017.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    高橋雅彦

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新規Tax1結合因子を介したHTLV-1発癌の悪性化機構

    2011.4 - 2013.3

    System name:科学研究費助成事業

    Research category:若手研究(B)

    Awarding organization:日本学術振興会

    高橋雅彦

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • HTLV1遺伝子発現のエピジェネティックな抑制機構

    2005.4 - 2007.3

    System name:科学研究費助成事業

    Research category:若手研究(B)

    Awarding organization:日本学術振興会

    高橋雅彦

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\3500000 ( Direct Cost: \3500000 )

    researchmap

▶ display all